HomeMTNB • NYSEAMERICAN
add
Matinas BioPharma Holdings Inc
Previous close
$3.59
Day range
$3.52 - $3.64
Year range
$3.28 - $44.50
Market cap
17.66M USD
Avg Volume
50.82K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.47M | -5.08% |
Net income | -5.72M | 5.63% |
Net profit margin | — | — |
Earnings per share | -0.02 | 98.67% |
EBITDA | -5.75M | 5.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.31M | -36.42% |
Total assets | 24.36M | -28.39% |
Total liabilities | 5.26M | -14.73% |
Total equity | 19.10M | — |
Shares outstanding | 5.02M | — |
Price to book | 0.94 | — |
Return on assets | -66.39% | — |
Return on capital | -72.44% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.72M | 5.63% |
Cash from operations | -3.11M | -41.63% |
Cash from investing | -2.94M | -147.40% |
Cash from financing | 9.19M | 919,000.00% |
Net change in cash | 3.14M | -21.45% |
Free cash flow | -860.38K | -599.49% |
About
Founded
2013
Headquarters
Website
Employees
32